tradingkey.logo

BRIEF-Corcept Submits New Drug Application For Relacorilant As A Treatment For Patients With Hypercortisolism

ReutersDec 30, 2024 10:31 PM

- Corcept Therapeutics Inc CORT.O:

  • CORCEPT SUBMITS NEW DRUG APPLICATION FOR RELACORILANT AS A TREATMENT FOR PATIENTS WITH HYPERCORTISOLISM

Source text: ID:nBw8CyRMHa

Further company coverage: CORT.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI